Design Therapeutics Statistics
Total Valuation
DSGN has a market cap or net worth of $249.71 million. The enterprise value is -$18.84 million.
Market Cap | 249.71M |
Enterprise Value | -18.84M |
Important Dates
The last earnings date was Wednesday, May 8, 2024, after market close.
Earnings Date | May 8, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
DSGN has 56.50 million shares outstanding. The number of shares has increased by 1.04% in one year.
Shares Outstanding | 56.50M |
Shares Change (YoY) | +1.04% |
Shares Change (QoQ) | +0.71% |
Owned by Insiders (%) | 36.54% |
Owned by Institutions (%) | 54.63% |
Float | 24.29M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.93 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 38.61, with a Debt / Equity ratio of 0.01.
Current Ratio | 38.61 |
Quick Ratio | n/a |
Debt / Equity | 0.01 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -20.80% and return on invested capital (ROIC) is -26.11%.
Return on Equity (ROE) | -20.80% |
Return on Assets (ROA) | -19.90% |
Return on Capital (ROIC) | -26.11% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.03M |
Employee Count | 57 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -35.53% in the last 52 weeks. The beta is 1.84, so DSGN's price volatility has been higher than the market average.
Beta (1Y) | 1.84 |
52-Week Price Change | -35.53% |
50-Day Moving Average | 3.69 |
200-Day Moving Average | 2.92 |
Relative Strength Index (RSI) | 60.61 |
Average Volume (30 Days) | 308,940 |
Short Selling Information
The latest short interest is 2.99 million, so 5.29% of the outstanding shares have been sold short.
Short Interest | 2.99M |
Short Previous Month | 2.39M |
Short % of Shares Out | 5.29% |
Short % of Float | 12.29% |
Short Ratio (days to cover) | 10.97 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -70.94M |
Pretax Income | -58.67M |
Net Income | -58.67M |
EBITDA | -58.10M |
EBIT | -58.67M |
Earnings Per Share (EPS) | -$1.05 |
Balance Sheet
The company has $270.69 million in cash and $2.14 million in debt, giving a net cash position of $268.54 million or $4.75 per share.
Cash & Cash Equivalents | 270.69M |
Total Debt | 2.14M |
Net Cash | 268.54M |
Net Cash Per Share | $4.75 |
Equity / Book Value | 269.56M |
Book Value Per Share | 4.77 |
Working Capital | 266.79M |
Cash Flow
In the last 12 months, operating cash flow was -$53.58 million and capital expenditures -$364,000, giving a free cash flow of -$53.94 million.
Operating Cash Flow | -53.58M |
Capital Expenditures | -364,000 |
Free Cash Flow | -53.94M |
FCF Per Share | -$0.96 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
DSGN does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -1.04% |
Shareholder Yield | -1.04% |
Earnings Yield | -23.50% |
FCF Yield | -21.60% |
Analyst Forecast
The average price target for DSGN is $6.75, which is 53.06% higher than the current price. The consensus rating is "Hold".
Price Target | $6.75 |
Price Target Difference | 53.06% |
Analyst Consensus | Hold |
Analyst Count | 4 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | 3.42% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 3 |